PRIMARY HYPEROXALURIA TYPE 1

Clinical trials for PRIMARY HYPEROXALURIA TYPE 1 explained in plain language.

Never miss a new study

Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear

Sign up with your email to follow new studies for PRIMARY HYPEROXALURIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Promising drug may help kids with rare kidney disorder avoid dialysis

Disease control Completed

This study tested a drug called nedosiran in 27 children from birth to 11 years old who have primary hyperoxaluria, a rare condition that causes harmful oxalate buildup and can lead to kidney failure. The goal was to see if the drug safely lowers oxalate levels in the urine, whic…

Matched conditions: PRIMARY HYPEROXALURIA TYPE 1

Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control

Last updated May 04, 2026 16:17 UTC

PRIMARY HYPEROXALURIA TYPE 1

Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear

Promising drug may help kids with rare kidney disorder avoid dialysis